Patents Assigned to HANGZHOU NORMAL UNIVERSITY
-
Patent number: 12233382Abstract: A preparation method of an antifouling and hydrophilic polyethersulfone ultrafiltration membrane includes through the 60Co-? radiation grafting chemical modification method, evenly distributing an ionic liquid on a surface of a polyethersulfone material, wherein the ionic liquid containing unsaturated bonds is connected with the polyethersulfone material through chemical bonds, and then obtaining an asymmetric porous membrane by the immersion-precipitation phase transformation method, and finally performing Soxhlet extraction on the porous membrane, so as to migrate the grafted ionic liquid from an interior of the porous membrane to a surface of the porous membrane to be enriched, so that the adsorption and antibacterial properties of the porous membrane are improved. A mass ratio of the ionic liquid to the polyethersulfone material is in a range of (2-11):100.Type: GrantFiled: November 30, 2021Date of Patent: February 25, 2025Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Yongjin Li, Chunjun Ni, Xin Zheng
-
Patent number: 11981630Abstract: Disclosed are an abietane type diterpene compound, a preparation method and an application thereof, relating to the technical field of anti-tumor compounds, where the compound has a chemical structure as shown in the following formula I: Leucosceptrum canum is extracted to prepare the abietane type diterpene compound according to the present application, and the prepared compound is effectively applied in inhibiting human lung cancer cell A549 and human myeloid leukemia cell HL-60.Type: GrantFiled: January 31, 2023Date of Patent: May 14, 2024Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Mingfeng Xu, Xiaohong Deng, Jinfeng Liang, Yidi Chen, Jing Ren, Qin Zhu
-
Patent number: 11722887Abstract: A privacy protection authentication method based on a wireless body area network may be applied to a smart home care system. The method provides an authentication method for two-way authentication and key verification between a device and a cloud server, can ensure identities of the device and the cloud server to be valid and prevent network information security from being affected by external invasion attacks. A physical unclonable function and an elliptic curve cryptography algorithm are introduced to encrypt key data in the authentication process, so that the whole authentication process is in a safe environment, and the security of the authentication process is further improved through adding and removing functions of a third-party identity. The privacy protection authentication protocol method can resist replay attacks and smart card impersonation attacks, the whole authentication process is safe and efficient, and has a high application value in smart home care scenes.Type: GrantFiled: August 23, 2022Date of Patent: August 8, 2023Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Qi Xie, Xiumei Li, Dongnan Liu, Zixuan Ding, Bin Hu, Xiao Tan, Lidong Han
-
Patent number: 11577228Abstract: The present invention relates to the field of catalysts, and provides a porous layered transition metal dichalcogenide (TMD) and a preparation method and use thereof. The preparation method includes the following steps: (1) mixing silica microspheres, a transition metal salt and an elemental chalcogen, and pressing to obtain a tablet, the silica microspheres having a same or different particle diameters; and (2) sintering the tablet under hydrogen, and removing the silica microspheres to obtain the porous layered TMD. The porous layered TMD prepared by the method of the present invention has a high lattice edge exposure, which provides more active sites and higher catalytic activity, so the porous layered TMD can effectively catalyze the oxidation of alcohols to aldehydes or sulfides to sulfoxides under visible light irradiation.Type: GrantFiled: July 17, 2020Date of Patent: February 14, 2023Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Cheng Wang, Weiming Xu, Huilin Zheng, Pengfei Zhang, Hongyun Shen, Xiaoling Li
-
Patent number: 11414415Abstract: The present invention relates to the technical field of chemical synthesis of pharmaceutical chemicals, and provides a 6H-imidazo[4,5,1-ij]quinolone, a synthesis method and use thereof. 6H-imidazo[4,5,1-ij]quinolone derivatives provided by the present invention are a novel group of active quinolone derivatives, which have tumor cell inhibition activity and exhibit IC50 values equivalent to anti-lung cancer drug osimertinib; these quinolone derivatives have a broad application prospect in the preparation of antitumor drugs. The 6H-imidazo[4,5,1-ij]quinolone provided by the present invention is of high research and application value and has potential application prospects in fields of pharmaceutical chemicals, materials, dyes, etc. The present invention uses thioquinolinamide as a raw material to synthesize 6H-imidazo[4,5,1-ij]quinolones, featuring simple operation, excellent selectivity, high yield, mild reaction conditions, and easy product separation.Type: GrantFiled: June 19, 2020Date of Patent: August 16, 2022Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Pengfei Zhang, Wei Huang, Chao Shen, Jun Xu, Jiabin Shen, Weiming Xu
-
Patent number: 11161809Abstract: The disclosure provides processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindac, relating to the field of medicine. The former comprises mixing 6-fluoro-2-methyl-1-indanone, cyanoacetic acid, a first organic solvent and an acetic acid-based catalyst to proceed with a first condensation reaction to give a first condensation reaction solution, which contains 5-fluoro-2-methyl-3-indanacetonitrile; and mixing the first condensation reaction solution, per se, with a base, a second organic solvent and 4-(methylthio)benzaldehyde to proceed with a second condensation reaction to give 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile. The process is a one-pot process without separation of 5-fluoro-2-methyl-3-indanacetonitrile from the solvent, shortening the synthetic route, simplifying the preparation process and improving the 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile yield.Type: GrantFiled: April 21, 2020Date of Patent: November 2, 2021Assignees: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTDInventors: Weiming Xu, Wanmei Li, Lianzhi Tao, Pengfei Zhang, Hongyun Shen, Dongxiang Feng
-
Patent number: 11161818Abstract: A novel quinolone derivative and methods of its preparation are described in which the novel derivative comprises a diphenyl ether substituent on the nitrogen atom at the 1-position of the main quinolone ring. The novel derivative is shown to have antibacterial and anti-tumor cell activity.Type: GrantFiled: March 24, 2020Date of Patent: November 2, 2021Assignee: HANGZHOU NORMAL UNIVERSITYInventors: Pengfei Zhang, Wanmei Li, Weiming Xu, Haifeng Wu
-
Publication number: 20210276947Abstract: The disclosure provides processes for preparing 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile and for preparing sulindac, relating to the field of medicine. The former comprises mixing 6-fluoro-2-methyl-1-indanone, cyanoacetic acid, a first organic solvent and an acetic acid-based catalyst to proceed with a first condensation reaction to give a first condensation reaction solution, which contains 5-fluoro-2-methyl-3-indanacetonitrile; and mixing the first condensation reaction solution, per se, with a base, a second organic solvent and 4-(methylthio)benzaldehyde to proceed with a second condensation reaction to give 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile. The process is a one-pot process without separation of 5-fluoro-2-methyl-3-indanacetonitrile from the solvent, shortening the synthetic route, simplifying the preparation process and improving the 5-fluoro-2-methyl-1-(4-methylthiobenzylidene)-3-indanacetonitrile yield.Type: ApplicationFiled: April 21, 2020Publication date: September 9, 2021Applicants: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTDInventors: Weiming XU, Wanmei LI, Lianzhi TAO, Pengfei ZHANG, Hongyun SHEN, Dongxiang FENG
-
Patent number: 10611721Abstract: The present invention provides a method for preparing levobunolol hydrochloride. In the present invention S-1-tert-butyl-epoxy methylamine is subjected to a substitution reaction with 5-hydroxy-1-tetralone, and acidified to obtain the target product levobunolol hydrochloride. The method provided by the present invention greatly improves the regioselectivity of the reaction, avoids the occurrence of side reactions, and effectively improves the yield and optical purity of levobunolol hydrochloride, with the yield being 87.3%, and the ee value being over 99%.Type: GrantFiled: October 18, 2018Date of Patent: April 7, 2020Assignees: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTDInventors: Weiming Xu, Pengfei Zhang, Dongxiang Feng, Lianzhi Tao
-
Patent number: 10604466Abstract: The present invention provides a method for preparing a resveratrol compound, and belongs to the technical field of organic synthesis. In the present invention, first alkoxy-substituted benzyl halide, alkoxy-substituted benzaldehyde and a metal catalyst are subjected to oxidative addition and reduction elimination reactions to obtain alkoxy-substituted diphenylethanone; and then the alkoxy-substituted diphenylethanone and a metal catalyst are subjected to reduction, trans elimination and selective debenzylation reactions under a hydrogen atmosphere to obtain the resveratrol compound. In the preparation method of the present invention, the hydrogenation reduction, trans elimination and selective debenzylation reactions can be achieved just by a one-pot process, where the reaction directly obtains a trans olefin, thereby avoiding the formation of a isomer; and also the reaction selectively catalyzes debenzylation to eliminate Lewis acids from the source, and has the advantage of a high yield.Type: GrantFiled: September 5, 2019Date of Patent: March 31, 2020Assignees: HANGZHOU NORMAL UNIVERSITY, GREAT FOREST BIOMEDICAL LTD.Inventors: Weiming Xu, Wanmei Li, Xiaoling Li, Pengfei Zhang, Jinsong Wang, Kejie Chai
-
Publication number: 20200071259Abstract: The present invention provides a method for preparing levobunolol hydrochloride. In the present invention S-1-tert-butyl-epoxy methylamine is subjected to a substitution reaction with 5-hydroxy-1-tetralone, and acidified to obtain the target product levobunolol hydrochloride. The method provided by the present invention greatly improves the regioselectivity of the reaction, avoids the occurrence of side reactions, and effectively improves the yield and optical purity of levobunolol hydrochloride, with the yield being 87.3%, and the ee value being over 99%.Type: ApplicationFiled: October 18, 2018Publication date: March 5, 2020Applicants: HANGZHOU NORMAL UNIVERSITY, HANGZHOU LOOP BIOTECH CO., LTDInventors: Weiming Xu, Pengfei Zhang, Dongxiang Feng, Lianzhi Tao
-
Patent number: 9051254Abstract: The present invention describes a novel synthetic method for preparing the key intermediate 2,6,10-trimethyl-1,1-dialkoxy-3,5,9-undecatriene of lycopene. An existing synthetic method have some disadvantages that it is very difficult to gain the raw material dialkyl 4-methyl-5,5-diakoxy-1-pentene-1-phosphonate (10) because no effective synthetic method can be adopted, and furthermore the obtained target compound is composed of several cis/trans isomers. This invention relates to a process comprising a condensation step wherein a starting C10-phosphonate is changed to its carbanion completely at a temperature of ?40˜30 under an atmosphere of a non-reactive gas in an organic solvent catalyzed by base, and then C4-dialkyl is added to undergo Wittig-Horner condensation. This invention affords all trans C14-acetal and this method is characterized with the advantages of simple procedure, easy access to raw material and low cost, which makes it has the value of industrial application.Type: GrantFiled: June 11, 2012Date of Patent: June 9, 2015Assignees: HANGZHOU NORMAL UNIVERSITY, UNIVERSITY OF SHAOXINGInventors: Pengfei Zhang, Chao Shen, Runpu Shen, Wei Liu, Chunlei Wu
-
Publication number: 20120316366Abstract: The present invention describes a novel synthetic method for preparing the key intermediate 2,6,10-trimethyl-1,1-dialkoxy-3,5,9-undecatriene of lycopene. An existing synthetic method have some disadvantages that it is very difficult to gain the raw material dialkyl 4-methyl-5,5-diakoxy-1-pentene-1-phosphonate (10) because no effective synthetic method can be adopted, and furthermore the obtained target compound is composed of several cis/trans isomers. This invention relates to a process comprising a condensation step wherein a starting C10-phosphonate is changed to its carbanion completely at a temperature of ?40˜30 under an atmosphere of a non-reactive gas in an organic solvent catalyzed by base, and then C4-dialkyl is added to undergo Wittig-Horner condensation. This invention affords all trans C14-acetal and this method is characterized with the advantages of simple procedure, easy access to raw material and low cost, which makes it has the value of industrial application.Type: ApplicationFiled: June 11, 2012Publication date: December 13, 2012Applicants: UNIVERSITY OF SHAOXING, HANGZHOU NORMAL UNIVERSITYInventors: PENGFEI ZHANG, CHAO SHEN, RUNPU SHEN, WEI LIU, CHUNLEI WU